{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T22:09:41Z","timestamp":1790978981162,"version":"4.1.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T00:00:00Z","timestamp":1300147200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2011,7]]},"DOI":"10.1038\/leu.2011.43","type":"journal-article","created":{"date-parts":[[2011,3,15]],"date-time":"2011-03-15T13:45:07Z","timestamp":1300196707000},"page":"1174-1181","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":152,"title":["A novel role for CCL3 (MIP-1\u03b1) in myeloma-induced bone disease via osteocalcin downregulation and inhibition of osteoblast function"],"prefix":"10.1038","volume":"25","author":[{"given":"S","family":"Vallet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Vaghela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M T","family":"Fulciniti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Veiby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hideshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Santo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cirstea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D T","family":"Scadden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K C","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Raje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,3,15]]},"reference":[{"key":"BFleu201143_CR1","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1002\/cncr.22991","volume":"110","author":"F Saad","year":"2007","unstructured":"Saad F, Lipton A, Cook R, Chen YM, Smith M, Coleman R . Pathologic fractures correlate with reduced survival in patients with malignant bone disease. Cancer 2007; 110: 1860\u20131867.","journal-title":"Cancer"},{"key":"BFleu201143_CR2","doi-asserted-by":"publisher","first-page":"1909","DOI":"10.1200\/JCO.1989.7.12.1909","volume":"7","author":"R Bataille","year":"1989","unstructured":"Bataille R, Chappard D, Marcelli C, Dessauw P, Sany J, Baldet P et al. Mechanisms of bone destruction in multiple myeloma: the importance of an unbalanced process in determining the severity of lytic bone disease. J Clin Oncol 1989; 7: 1909\u20131914.","journal-title":"J Clin Oncol"},{"key":"BFleu201143_CR3","doi-asserted-by":"publisher","first-page":"3349","DOI":"10.1182\/blood.V97.11.3349","volume":"97","author":"JH Han","year":"2001","unstructured":"Han JH, Choi SJ, Kurihara N, Koide M, Oba Y, Roodman GD . Macrophage inflammatory protein-1alpha is an osteoclastogenic factor in myeloma that is independent of receptor activator of nuclear factor kappaB ligand. Blood 2001; 97: 3349\u20133353.","journal-title":"Blood"},{"key":"BFleu201143_CR4","doi-asserted-by":"publisher","first-page":"3568","DOI":"10.1182\/blood-2002-08-2383","volume":"101","author":"S Lentzsch","year":"2003","unstructured":"Lentzsch S, Gries M, Janz M, Bargou R, Dorken B, Mapara MY . Macrophage inflammatory protein 1-alpha (MIP-1 alpha) triggers migration and signaling cascades mediating survival and proliferation in multiple myeloma (MM) cells. Blood 2003; 101: 3568\u20133573.","journal-title":"Blood"},{"key":"BFleu201143_CR5","doi-asserted-by":"publisher","first-page":"3744","DOI":"10.1182\/blood-2007-05-093294","volume":"110","author":"S Vallet","year":"2007","unstructured":"Vallet S, Raje N, Ishitsuka K, Hideshima T, Podar K, Chhetri S et al. MLN3897, a novel CCR1 inhibitor, impairs osteoclastogenesis and inhibits the interaction of multiple myeloma cells and osteoclasts. Blood 2007; 110: 3744\u20133752.","journal-title":"Blood"},{"key":"BFleu201143_CR6","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/S1043-4666(03)00106-6","volume":"22","author":"S Abbas","year":"2003","unstructured":"Abbas S, Zhang YH, Clohisy JC, Abu-Amer Y . Tumor necrosis factor-alpha inhibits pre-osteoblast differentiation through its type-1 receptor. Cytokine 2003; 22: 33\u201341.","journal-title":"Cytokine"},{"key":"BFleu201143_CR7","doi-asserted-by":"publisher","first-page":"2324","DOI":"10.1210\/en.2005-0065","volume":"146","author":"S Yano","year":"2005","unstructured":"Yano S, Mentaverri R, Kanuparthi D, Bandyopadhyay S, Rivera A, Brown EM et al. Functional expression of beta-chemokine receptors in osteoblasts: role of regulated upon activation, normal T cell expressed and secreted (RANTES) in osteoblasts and regulation of its secretion by osteoblasts and osteoclasts. Endocrinology 2005; 146: 2324\u20132335.","journal-title":"Endocrinology"},{"key":"BFleu201143_CR8","doi-asserted-by":"publisher","first-page":"1434","DOI":"10.1359\/jbmr.090305","volume":"24","author":"C Vincent","year":"2009","unstructured":"Vincent C, Findlay DM, Welldon KJ, Wijenayaka AR, Zheng TS, Haynes DR et al. Pro-inflammatory cytokines TNF-related weak inducer of apoptosis (TWEAK) and TNFalpha induce the mitogen-activated protein kinase (MAPK)-dependent expression of sclerostin in human osteoblasts. J Bone Miner Res 2009; 24: 1434\u20131449.","journal-title":"J Bone Miner Res"},{"key":"BFleu201143_CR9","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1016\/S0301-472X(03)00023-7","volume":"31","author":"S Greenstein","year":"2003","unstructured":"Greenstein S, Krett NL, Kurosawa Y, Ma C, Chauhan D, Hideshima T et al. Characterization of the MM 1 human multiple myeloma (MM) cell lines: a model system to elucidate the characteristics, behavior, and signaling of steroid-sensitive and -resistant MM cells. Exp Hematol 2003; 31: 271\u2013282.","journal-title":"Exp Hematol"},{"key":"BFleu201143_CR10","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1038\/sj.thj.6200075","volume":"2","author":"R Burger","year":"2001","unstructured":"Burger R, Guenther A, Bakker F, Schmalzing M, Bernand S, Baum W et al. Gp130 and ras mediated signaling in human plasma cell line INA-6: a cytokine-regulated tumor model for plasmacytoma. Hematol J 2001; 2: 42\u201353.","journal-title":"Hematol J"},{"key":"BFleu201143_CR11","doi-asserted-by":"publisher","first-page":"5124","DOI":"10.1073\/pnas.0911929107","volume":"107","author":"S Vallet","year":"2010","unstructured":"Vallet S, Mukherjee S, Vaghela N, Hideshima T, Fulciniti M, Pozzi S et al. Activin A promotes multiple myeloma-induced osteolysis and is a promising target for myeloma bone disease. Pro Natl Acad Sci USA 2010; 107: 5124\u20135129.","journal-title":"Pro Natl Acad Sci USA"},{"key":"BFleu201143_CR12","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1016\/S8756-3282(97)00299-8","volume":"22","author":"P Derkx","year":"1998","unstructured":"Derkx P, Nigg AL, Bosman FT, Birkenhager-Frenkel DH, Houtsmuller AB, Pols HA et al. Immunolocalization and quantification of noncollagenous bone matrix proteins in methylmethacrylate-embedded adult human bone in combination with histomorphometry. Bone 1998; 22: 367\u2013373.","journal-title":"Bone"},{"key":"BFleu201143_CR13","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1182\/blood-2005-01-0373","volume":"106","author":"P Tassone","year":"2005","unstructured":"Tassone P, Neri P, Carrasco DR, Burger R, Goldmacher VS, Fram R et al. A clinically relevant SCID-hu in vivo model of human multiple myeloma. Blood 2005; 106: 713\u2013716.","journal-title":"Blood"},{"key":"BFleu201143_CR14","unstructured":"Rasband WS . ImageJ. In: US National Institutes of Health B, Maryland U, (eds) US National Institutes of Health: Bethesda, Maryland, USA. http:\/\/rsb.info.nih.gov\/ij\/; 1997\u20132006."},{"key":"BFleu201143_CR15","doi-asserted-by":"publisher","first-page":"3111","DOI":"10.1096\/fasebj.4.13.2210157","volume":"4","author":"GS Stein","year":"1990","unstructured":"Stein GS, Lian JB, Owen TA . Relationship of cell growth to the regulation of tissue-specific gene expression during osteoblast differentiation. Faseb J 1990; 4: 3111\u20133123.","journal-title":"Faseb J"},{"key":"BFleu201143_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1046\/j.1365-2141.2003.04040.x","volume":"120","author":"S Uneda","year":"2003","unstructured":"Uneda S, Hata H, Matsuno F, Harada N, Mitsuya Y, Kawano F et al. Macrophage inflammatory protein-1 alpha is produced by human multiple myeloma (MM) cells and its expression correlates with bone lesions in patients with MM. Br J Haematol 2003; 120: 53\u201355.","journal-title":"Br J Haematol"},{"key":"BFleu201143_CR17","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1182\/blood.V85.4.997.bloodjournal854997","volume":"85","author":"BA Roecklein","year":"1995","unstructured":"Roecklein BA, Torok-Storb B . Functionally distinct human marrow stromal cell lines immortalized by transduction with the human papilloma virus E6\/E7 genes. Blood 1995; 85: 997\u20131005.","journal-title":"Blood"},{"key":"BFleu201143_CR18","doi-asserted-by":"publisher","first-page":"1509","DOI":"10.1182\/blood-2002-03-0844","volume":"100","author":"L Graf","year":"2002","unstructured":"Graf L, Iwata M, Torok-Storb B . Gene expression profiling of the functionally distinct human bone marrow stromal cell lines HS-5 and HS-27a. Blood 2002; 100: 1509\u20131511.","journal-title":"Blood"},{"key":"BFleu201143_CR19","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/S8756-3282(98)00092-1","volume":"23","author":"AL Boskey","year":"1998","unstructured":"Boskey AL, Gadaleta S, Gundberg C, Doty SB, Ducy P, Karsenty G . Fourier transform infrared microspectroscopic analysis of bones of osteocalcin-deficient mice provides insight into the function of osteocalcin. Bone 1998; 23: 187\u2013196.","journal-title":"Bone"},{"key":"BFleu201143_CR20","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.jmbbm.2008.10.010","volume":"2","author":"NB Kavukcuoglu","year":"2009","unstructured":"Kavukcuoglu NB, Patterson-Buckendahl P, Mann AB . Effect of osteocalcin deficiency on the nanomechanics and chemistry of mouse bones. J Mechan Behav Biomed Materials 2009; 2: 348\u2013354.","journal-title":"J Mechan Behav Biomed Materials"},{"key":"BFleu201143_CR21","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1046\/j.1365-2141.2003.04561.x","volume":"123","author":"E Terpos","year":"2003","unstructured":"Terpos E, Politou M, Szydlo R, Goldman JM, Apperley JF, Rahemtulla A . Serum levels of macrophage inflammatory protein-1 alpha (MIP-1alpha) correlate with the extent of bone disease and survival in patients with multiple myeloma. Br J Haematol 2003; 123: 106\u2013109.","journal-title":"Br J Haematol"},{"key":"BFleu201143_CR22","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1182\/blood-2004-09-3507","volume":"106","author":"V Sordi","year":"2005","unstructured":"Sordi V, Malosio ML, Marchesi F, Mercalli A, Melzi R, Giordano T et al. Bone marrow mesenchymal stem cells express a restricted set of functionally active chemokine receptors capable of promoting migration to pancreatic islets. Blood 2005; 106: 419\u2013427.","journal-title":"Blood"},{"key":"BFleu201143_CR23","doi-asserted-by":"publisher","first-page":"1030","DOI":"10.1634\/stemcells.2005-0319","volume":"24","author":"M Honczarenko","year":"2006","unstructured":"Honczarenko M, Le Y, Swierkowski M, Ghiran I, Glodek AM, Silberstein LE . Human bone marrow stromal cells express a distinct set of biologically functional chemokine receptors. Stem cells (Dayton, Ohio) 2006; 24: 1030\u20131041.","journal-title":"Stem cells (Dayton, Ohio)"},{"key":"BFleu201143_CR24","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.1182\/blood-2004-12-4986","volume":"106","author":"N Giuliani","year":"2005","unstructured":"Giuliani N, Colla S, Morandi F, Lazzaretti M, Sala R, Bonomini S et al. Myeloma cells block RUNX2\/CBFA1 activity in human bone marrow osteoblast progenitors and inhibit osteoblast formation and differentiation. Blood 2005; 106: 2472\u20132483.","journal-title":"Blood"},{"key":"BFleu201143_CR25","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1056\/NEJMoa030847","volume":"349","author":"E Tian","year":"2003","unstructured":"Tian E, Zhan F, Walker R, Rasmussen E, Ma Y, Barlogie B et al. The role of the Wnt-signaling antagonist DKK1 in the development of osteolytic lesions in multiple myeloma. N Engl J Med 2003; 349: 2483\u20132494.","journal-title":"N Engl J Med"},{"key":"BFleu201143_CR26","doi-asserted-by":"publisher","first-page":"6297","DOI":"10.1074\/jbc.M507804200","volume":"281","author":"X Lu","year":"2006","unstructured":"Lu X, Gilbert L, He X, Rubin J, Nanes MS . Transcriptional regulation of the osterix (Osx, Sp7) promoter by tumor necrosis factor identifies disparate effects of mitogen-activated protein kinase and NF kappa B pathways. J Biol Chem 2006; 281: 6297\u20136306.","journal-title":"J Biol Chem"},{"key":"BFleu201143_CR27","doi-asserted-by":"publisher","first-page":"2177","DOI":"10.1038\/leu.2009.130","volume":"23","author":"M Roussou","year":"2009","unstructured":"Roussou M, Tasidou A, Dimopoulos MA, Kastritis E, Migkou M, Christoulas D et al. Increased expression of macrophage inflammatory protein-1alpha on trephine biopsies correlates with extensive bone disease, increased angiogenesis and advanced stage in newly diagnosed patients with multiple myeloma. Leukemia 2009; 23: 2177\u20132181.","journal-title":"Leukemia"},{"key":"BFleu201143_CR28","doi-asserted-by":"publisher","first-page":"d804","DOI":"10.2741\/A323","volume":"3","author":"RA Hipskind","year":"1998","unstructured":"Hipskind RA, Bilbe G . MAP kinase signaling cascades and gene expression in osteoblasts. Front Biosci 1998; 3: d804\u2013d816.","journal-title":"Front Biosci"},{"key":"BFleu201143_CR29","doi-asserted-by":"publisher","first-page":"1785","DOI":"10.1359\/jbmr.2002.17.10.1785","volume":"17","author":"C Higuchi","year":"2002","unstructured":"Higuchi C, Myoui A, Hashimoto N, Kuriyama K, Yoshioka K, Yoshikawa H et al. Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res 2002; 17: 1785\u20131794.","journal-title":"J Bone Miner Res"},{"key":"BFleu201143_CR30","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1016\/j.bone.2006.07.024","volume":"40","author":"SJ Kono","year":"2007","unstructured":"Kono SJ, Oshima Y, Hoshi K, Bonewald LF, Oda H, Nakamura K et al. Erk pathways negatively regulate matrix mineralization. Bone 2007; 40: 68\u201374.","journal-title":"Bone"},{"key":"BFleu201143_CR31","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/jcp.21323","volume":"215","author":"A Raucci","year":"2008","unstructured":"Raucci A, Bellosta P, Grassi R, Basilico C, Mansukhani A . Osteoblast proliferation or differentiation is regulated by relative strengths of opposing signaling pathways. J Cell Physiol 2008; 215: 442\u2013451.","journal-title":"J Cell Physiol"}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/leu201143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201143","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/leu201143.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T14:12:50Z","timestamp":1648735970000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/leu201143"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,3,15]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2011,7]]}},"alternative-id":["BFleu201143"],"URL":"https:\/\/doi.org\/10.1038\/leu.2011.43","relation":{},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,3,15]]},"assertion":[{"value":"26 September 2010","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 January 2011","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 February 2011","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 March 2011","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The author NR is consultant for Celgene and Novartis, member of the advisory committee for Celgene and Amgen, and she had received research funding from Astra Zeneca and Acetylon. PV is an employee of Millennium Pharmaceuticals.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}